That's two! After the Pfizer-BioNTech vaccine, it is now the Moderna one which received a conditional marketing authorisation from the EU on Wednesday 6 January (see EUROPE B12627A3). The European Commission has thus followed the recommendations of the European Medicines Agency (EMA) made public a few hours earlier.
In total, the EU has ordered 160 million doses from the US biotech company, to be delivered between the first and third quarter of 2021. This approval should give a boost to...